Bioanalysis

  • Bioanalysis
  • Integrated Bioanalytical Solutions for Simple and Complex Assays

     

    Your Go-To Bioanalytical Team for Simple and Complex Assays

    For your simple or most complex assay needs, Altasciences delivers.

    With over 25 years of experience, Altasciences provides integrated bioanalytical solutions for your  assay needs. How? Our 260+ bioanalytical experts are experienced with a variety of compounds and use the latest instrumentation to deliver quality data quickly. 

    All bioanalytical solutions are available as stand-alone services to complement your external studies, or as a part of an integrated package with other Altasciences drug development solutions. We offer you complete flexibility. 

    Our bioanalytical solutions include: 

    • Analyst support available 24/7 when needed
    • State-of-the-art equipment
    • Over 650 methods that can be leveraged as an off-the-shelf solution
    • Proven regulatory excellence
    • Flexible support service offering: scientific writing, project management, TK and PK analysis, and so much more.

    Speak with an expert to learn more about our bioanalytical capabilities that best suits your needs.

    You may also be interested in the following:

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
     

    Clinical Sample Kits — We Make It Easy

     

    Clinical Sample Kit Management

    From trial sites to our labs, Altasciences’ Material Management Team has over 25 years of experience supporting clinical trials around the globe. We make it easy with efficient collection, preparation and shipment of clinical samples.

    Each kit is adapted to your specific study needs, and allows for the storage and shipping of different matrices, such as plasma, urine, serum, and whole blood.
            
    Download our fact sheet to learn more about our capability or send us an e-mail and we will connect you with an expert within 24 hours.

    Download fact sheet Send e-mail

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    You may also be interested in the following:

    Parallelism Challenges When Using Commercial Kits for Biomarker Quantitation

    Seamless Bioanalytical Transition from Preclinical to Clinical, and Beyond

     

    Seamless Bioanalytical Transition

    Altasciences’ scientists move in unison with you, collaboratively, accurately, and efficiently, from preclinical to clinical, and beyond. Our team of over 260 bioanalytical scientific veterans is strategically located across North America, and has experience with a wide spectrum of biological matrices in both animal and humans.
     
    Driven by your assay requirements, our program support includes LC-MS/MS, LBA OR HYBRID LBA/LC-MS/MS ASSAY platforms for:

    • Small molecules
    • Peptides
    • Proteins
    • Antibody-drug conjugates (ADC)
    • Monoclonal antibodies (mAb)
    • Immunogenicity
    • Anti-drug antibody
    • Neutralizing assays
    • Biomarkers — single or packages
    • Oligonucleotides

    Speak with a scientist

    Have 5 minutes? You may also be interested in the following:


    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.

    Flow Cytometry — Integrated for Efficiency

     

    Altasciences’ preclinical and clinical sites share the same validation of instrumentation and panels to ensure a smooth transition. Our flow cytometry labs are located near our clinical pharmacology units, for rapid turnaround between sample collection and analysis.

    Preclinical Applications 
    • Immunotoxicology
    • Exposure confirmation (complement to PK evaluation) and on-target binding
    • Immunomodulation
    • Drug mechanism of action
    • Identification of potential biomarkers
    • Research/exploratory projects
    Clinical Applications 
    • Immunomodulation
    • Neutralization assays
    • PK/PD correlation
    • Receptor occupancy
    • Drug mechanism of action
    • Functional assays

    Let’s schedule a conversation to review your program needs.

    Speak with an expert

    You may also be interested in the following:


    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    One Integrated Solution for Meeting Your Preclinical to Clinical Drug Development Needs

    Multiplexed Cytokine Comparison Across Two Species Dosed with the Same Drug

    Detection of Plasma Cells and their Precursors in Bone Marrow and Peripheral Blood

    Evaluating Cytokine Data in Nonhuman Primate Safety Assessment Studies: A Correlation to Toxicity Outcomes

    COMPLIMENTARY WEBINAR ⁠— Cell-Based Assays

     

    Key Considerations for Developing
    Cell-Based Assays 

    In this complimentary webinar, Dr. Danielle Salha, Senior Director, Immunochemistry and Immunology, Ligand Binding Assays, discusses key parameters to consider during method development to support drug potency and immunogenicity characterization. 

    Topics covered:

    • Reducing development timelines and management of critical reagents
    • Important parameters to consider for NAb method development and for the development of potency assays
    • Management of critical reagents to support long-term clinical studies
    • Advantages of using the same method for both immunogenicity assessment and product characterization
    • Challenges that may be encountered when developing cell-based assays

    Watch now

    You may also be interested in the following:

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    Subscribe to Bioanalysis